UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8‑K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
August 11, 2015
INOGEN, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
001-36309 |
|
33-0989359 |
|
(State or other jurisdiction of |
|
(Commission |
|
(IRS Employer |
326 Bollay Drive
Goleta, California 93117
(Address of principal executive offices, including zip code)
(805) 562-0500
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On August 11, 2015, Inogen, Inc. issued a press release reporting its financial results for the second quarter ended June 30, 2015. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02, and Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this current report shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof regardless of any general incorporation language in any such filing, unless the registrant expressly sets forth in such filing that such information is to be considered "filed" or incorporated by reference therein.
|
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits
|
|
|
|
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release, dated August 11, 2015. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
INOGEN, INC. |
||
|
|
|
|
|
|
|
|
|
By: |
|
/s/Alison Bauerlein |
|
|
|
|
|
Alison Bauerlein Executive Vice President, Finance, Chief Financial Officer, Secretary and Treasurer |
Date: August 11, 2015
|
Exhibit |
|
Description |
|
|
|
|
|
|
|
99.1 |
|
Press Release, dated August 11, 2015. |
|